Comparação da bioequivalência entre duas formulações de pregabalina 150 mg cápsula gelatinosa dura em voluntários sadios após a administração de dose única

Bellorio, Karini Bruno; Abreu, Fernanda Cruvinel de; Mendonça, Mariellen Clemente; Souza, Weidson Carlo de; Caçula, Ana Carolina Costa Sampaio Mendes; Morais, Douglas Costa; Souza, Carla Graziella Queiroga; Savio, Daniele; Pengo, Sérgio.
RBM rev. bras. med ; 71(4)abr. 2014.
Artículo en Portugués | LILACS | ID: lil-721596

Documentos relacionados

  1. Comparação da bioequivalência entre duas formulações de montelucaste de sódio 10 mg comprimidos revestidos em voluntários sadios após a administração de dose única
  2. An Improved LC-ESI-MS/MS Method to Quantify Pregabalin in Human Plasma and Dry Plasma Spot for Therapeutic Monitoring and Pharmacokinetic Applications.
  3. Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.
  4. Training the next generation of pharmacometric modelers: a multisector perspective.
  5. Low-dimensional neural ODEs and their application in pharmacokinetics.
  6. Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation.
  7. Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.
  8. Development of An HPLC Method for the Determination of Mesalazine in Human Plasma by Fluorimetric Derivatization and Application to A Prototype Pharmacokinetic Study.
  9. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers
  10. Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations.